Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Panc-1 |
Human exocrine pancreas carcinoma cells | ATCC CRL-1469 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | X. Wu et al., PNAS, Nov 2016, 113: E6965 - E6973 | ||
Panc-1 |
Human exocrine pancreas carcinoma cells | ATCC CRL-1469 | Human | digestive organs | cell line | adherent | plasmid | K2 Transfection System | publication | L. Hartl et al., Cancers, 2020, 12, 2546, doi:10.3390/cancers12092546 | Link | ||
Panc-1 |
Human exocrine pancreas carcinoma cells | ATCC CRL-1469 | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | X. Wu et al., PNAS, Nov 2016, 113: E6965 - E6973 | |||
Panc-1 |
Human exocrine pancreas carcinoma cells | ATCC CRL-1469 | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | X. Wu et al., PNAS, Nov 2016, 113: E6965 - E6973 | ||
Panc-1 |
Human exocrine pancreas carcinoma cells | ATCC CRL-1469 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | S. Cogoi et al., Nucleic Acids Res., Apr 2013; 41: 4049 - 4064 | Link | |
Panc-1 |
Human exocrine pancreas carcinoma cells | ATCC CRL-1469 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | A. D. Konitsiotis et al., PLoS ONE, 2014, 9(3): e89899, doi:10.1371/journal.pone.0089899 | Link | |
Panc-1 |
Human exocrine pancreas carcinoma cells | ATCC CRL-1469 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | X. Wu et al., PNAS, Nov 2016, 113: E6965 - E6973 | ||
Panc-1 |
Human exocrine pancreas carcinoma cells | ATCC CRL-1469 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | N. Walter et al., Am. Vac. Biointerphases, 2011, 6(2), DOI: 10.1116/1.3601755 | Link | ||
Panc-1 |
Human exocrine pancreas carcinoma cells | ATCC CRL-1469 | Human | digestive organs | cell line | adherent | plasmid | K2 Transfection System | publication | A. Carozzoa et al., Mol. Pharmacology, 2019, 115444, DOI: 10.1124/mol.118.115444 | Link | ||
PC-3 |
Human prostate cancer cell line | ATCC CRL-1435 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | E. Werwein et al., Nucleic Acids Res., 2019, 47(1): 103–121, doi: 10.1093/nar/gky935 | Link | |
PC-3 |
Human prostate cancer cell line | ATCC CRL-1435 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. B. Morelli et al., BMC Cancer, 2014, 14:921, doi:10.1186/1471-2407-14-921 | Link | |
PC-3 |
Human prostate cancer cell line | ATCC CRL-1435 | Human | genital tract | cell line | adherent | plasmid | Metafectene EASY | publication | J. C. Romero Sandoval, PhD Thesis, 2014, Universitat de Barcelona | Link | ||
PC-3 |
Human prostate cancer cell line | ATCC CRL-1435 | Human | genital tract | cell line | adherent | oligonucleotide | DOTAP | publication | M. M. M. Enriquez ez al., PLoSONE13(11):e0206818, doi.org/10.1371/journal.pone.0206818 | Link | ||
PC-3 |
Human prostate cancer cell line | ATCC CRL-1435 | Human | genital tract | cell line | adherent | plasmid | Metafectene | publication | N. Harada et al., J. Biol. Chem., Aug 2007; 282: 22651 - 22661 | Link | ||
PC-3 |
Human prostate cancer cell line | ATCC CRL-1435 | Human | genital tract | cell line | adherent | plasmid | Metafectene PRO | publication | C. Morich, Dissertation, 2016, Georg-August University Göttingen | Link | ||
PC-3 |
Human prostate cancer cell line | ATCC CRL-1435 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. Steinmann et al., J. Biol. Chem., Vol. 288, No. 31, pp. 22257–22269, August 2, 2013 | Link | |
PC-3 |
Human prostate cancer cell line | ATCC CRL-1435 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | U. Weirauch et al., Nucleic Acid Therapeutics, 2013, 23 (4): 264-272, DOI: 10.1089/nat.2012.0407 | Link | |
PC-3 |
Human prostate cancer cell line | ATCC CRL-1435 | Human | genital tract | cell line | adherent | oligonucleotide | DOTAP | publication | E. Aubets et al., Int. J. Mol. Sci., 2021, 22(18): 10025, doi: 10.3390/ijms221810025 | Link | ||
PC-3 |
Human prostate cancer cell line | ATCC CRL-1435 | Human | genital tract | cell line | adherent | oligonucleotide | DOTAP | publication | A. Avinó et al., Protocols in Nucleic Acid Chemistry, 2020, 77: e78, doi: 10.1002/cpnc.78 | |||
PC-3 |
Human prostate cancer cell line | ATCC CRL-1435 | Human | genital tract | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | U. K. Mukhopadhyay et al., Cancer Res., Apr 2005; 65: 2872 - 2881 | Link | |
PC-3M |
Human prostate carcinoma cell line | Human | genital tract | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | A. L. Omara-Opyene et al., Lab Invest., 2004 Jul; 84(7):894-907 | |||
PC-6 |
Human small cell lung carcinoma | Human | respiratory system | cell line | adherent | plasmid | Metafectene PRO | publication | D. Safiulina et al., The EMBO J., 2019, 38: e99384, DOI 10.15252/embj.201899384 | Link | |||
PC-6 |
Human small cell lung carcinoma | Human | respiratory system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | D. Safiulina et al., The EMBO J., 2018, e99384, DOI 10.15252/embj.201899384 | Link | ||
PC-9 |
Human lung adenocarcinome cell line (formerly PC14) | ECACC 90071810 | Human | respiratory system | cell line | adherent | plasmid | Metafectene PRO | publication | H. N. Pfäffle et al., Cancer Res., Oct 2013; 73: 6254 - 6263 | Link | ||
PEC |
Human primary conjunctival cells | Human | sensory organs | primary cell | adherent | miRNA | Metafectene SI | publication | Q. Pilson et al., Scientific Reports, 2020, 10: 7484, doi.org/10.1038/s41598-020-64422-5 | Link |